Cargando…
Estimating the cost consequence of the early use of botulinum toxin in post-stroke spasticity: Secondary analysis of a randomised controlled trial
OBJECTIVE: To estimate the cost-consequence of treating spasticity early with botulinum toxin in the acute stroke unit. DESIGN: Secondary cost-consequence analysis, using data from a double-blind randomised-controlled trial. SETTING: Single-centre specialised stroke unit. SUBJECTS AND INTERVENTIONS:...
Autores principales: | Lindsay, Cameron, Humphreys, Ioan, Phillips, Ceri, Pandyan, Anand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912301/ https://www.ncbi.nlm.nih.gov/pubmed/36325678 http://dx.doi.org/10.1177/02692155221133522 |
Ejemplares similares
-
The early use of botulinum toxin in post-stroke spasticity: study protocol for a randomised controlled trial
por: Lindsay, Cameron, et al.
Publicado: (2014) -
Can the early use of botulinum toxin in post stroke spasticity reduce contracture development? A randomised controlled trial
por: Lindsay, Cameron, et al.
Publicado: (2020) -
The Central Effects of Botulinum Toxin in Dystonia and Spasticity
por: Hok, Pavel, et al.
Publicado: (2021) -
Botulinum toxin treatment of spasticity targeted to muscle endplates: an international, randomised, evaluator-blinded study comparing two different botulinum toxin injection strategies for the treatment of upper limb spasticity
por: Rekand, Tiina, et al.
Publicado: (2019) -
Guidelines for the use of botulinum toxin in movement disorders and spasticity
por: Jabeen, Afshan, et al.
Publicado: (2011)